Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness

Author： Harvey Philip D   Bowie Christopher R  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.2, 2005-02, pp. : 337-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Wide-Ranging Genomic Effects of Plasticisers and Related Compounds

By  

Current Drug Metabolism, Vol. 9, Iss. 4, 2008-01 ,pp. : 285-303

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy, Tolerability and Cost Effectiveness of Disease-Modifying Antirheumatic Drugs and Biologic Agents in Rheumatoid Arthritis

By Nurmohamed Michael T.   Dijkmans Ben A.C.  

Drugs, Vol. 65, Iss. 5, 2005-01 ,pp. : 661-694

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Cisapride in Children

By Vandenplas Y.   Benatar A.   Cools F.   Arana A.   Hegar B.   Hauser B.  

Pediatric Drugs, Vol. 3, Iss. 8, 2001-01 ,pp. : 559-573

Adis International

Access to resources Recommend Favorite

Efficacy of Olanzapine and Ziprasidone for the Treatment of Schizophrenia: A Systematic Review

By Matza Louis S.   Baker Timothy M.   Revicki Dennis A.  

CNS Drugs, Vol. 19, Iss. 6, 2005-01 ,pp. : 499-515

Adis International

Access to resources Recommend Favorite

Ziprasidone vs aripiprazole: similar efficacy in schizophrenia

By  

Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite